In this study, we demonstrated that elevating acetylation of Prx1 by HDAC6 inhibition in AD condition could recovered Aβ-induced oxidative stress followed by restoring excessive Ca2+ and mitochondrial axonal transport. Here, HDAC6 is linked to Alzheimer disease.